The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer - Wikidata - awgldk - TriplyDB

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

http://www.wikidata.org/entity/Q28266001

about

How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment Statistical Methods for Establishing Personalized Treatment Rules in Oncology Genomic profiling in luminal breast cancer Choline dehydrogenase polymorphism rs12676 is a functional variation and is associated with changes in human sperm cell function Laser capture microdissection technology Reverse phase protein microarrays advance to use in clinical trials Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel.Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics.MIDClass: microarray data classification by association rules and gene expression intervals.Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer.Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue.Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.Delineation of a FOXA1/ERα/AGR2 regulatory loop that is dysregulated in endocrine therapy-resistant breast cancer.Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial.Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.The changing role of pathology in breast cancer diagnosis and treatment.Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays.Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients Biologic characteristics of premalignant breast disease.High Expression of Three-Gene Signature Improves Prediction of Relapse-Free Survival in Estrogen Receptor-Positive and Node-Positive Breast Tumors.Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be t Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.

P2860

Q24658523-E3AF0321-3600-45C4-8884-67F980898505 Q26786366-0B944FDD-B17E-448E-B0EA-CE252E23F422 Q26862681-D7901ACA-15DD-43C6-AE8D-F6F728E02542 Q27303860-97D4A0AE-9B6E-45B0-ABB0-0AA814D048BA Q28250373-EC0A003A-885F-4699-A4E6-95CDA64C4422 Q28384553-A235F731-8730-4B4A-8C68-A86609BBDAD4 Q30245184-5B1122AB-ECCB-4B12-9B93-D0839422C7AE Q30318419-A61C1AA3-75FE-4BA8-A47A-0DBE6E9E577F Q30440216-3280A2A4-86D5-4A44-A66B-EFA3E7F6AB9C Q30660977-31AC0CA2-30A5-4BD9-8BF8-2E45ADD4D9E1 Q30854643-69DCF288-056A-49D0-AF8D-708793D59168 Q33472698-C65682CF-DB3D-45D4-9498-7F0710EF0CC7 Q33618520-A93598E4-18D0-4770-9C18-7569A367D966 Q33692020-D74A229D-E145-448C-8F5F-34BCC1DF612F Q33763903-6E56A30C-D29D-4F59-B34B-94372AC5D271 Q33794872-18344FD9-B1AD-4C5E-9CA0-3ACFC44CDC2A Q33834198-5BC1E9AA-2339-4B6D-B31C-F08C14820B4B Q33974237-44D76C9B-908E-4A61-BC44-100E5C397B45 Q34029272-F0A7A5B0-0D6B-45C0-9884-2CF3C63761BC Q34088976-B45A560B-3305-4F67-8C3F-E8A3CA4647D5 Q34171441-3974B583-B540-4429-9241-2BB43418861F Q34173474-F91AC30F-CDB0-4BC4-B46A-72FC3E408AA2 Q34311300-283E9B17-E7E1-4436-960E-96E5E8DC18D6 Q34374852-B786ED99-5E5B-48A0-B571-C852B54592DF Q34747157-1386798F-52D2-48D6-9B21-5E64AA2A9F67 Q35034575-18EFA30E-9AC7-4C66-AC19-008CF1105E68 Q35040111-27C80811-94F6-473F-BC19-B15BEDBB8DAF Q35082260-367D548F-1EA4-4047-AE2D-D04908E3D67E Q35440724-448DD92E-7333-42DC-B68B-7A7A6CDB490C Q35558070-168A3877-5DDF-49BA-BAE2-4EBD495C1C6F Q35583987-A7147449-8AD2-4012-9275-D1CA4814D28A Q35683583-899B45BB-13A4-4B85-8104-37463AF9C583 Q36117673-2F035185-B502-4949-B86C-DEE4614C8065 Q36204798-C81F1C45-F5AA-4EB9-B012-B61222BF793F Q36338015-B76F6BA5-1AA4-474C-81B7-FEE92DDF74E1 Q36393198-105117FC-5016-482A-8410-F759E92D88E8 Q36428743-5A07D6D6-08E5-4E0C-B5CE-1C614B6E6BBE Q36438352-E12DA318-F9F7-498E-A5AD-0C8417C33D72 Q36610188-713FF727-7044-4936-9E43-D53EFE079C60 Q36816034-DADF1466-9C80-4AEE-9693-A560C3411A88

P2860

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

http://www.wikidata.org/entity/Q28266001

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@ast

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@en

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@nl

type

label

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@ast

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@en

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@nl

prefLabel

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@ast

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@en

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@nl

P1433

Q28266001-20627C59-AFC6-41E4-B89B-9788909D3F2C

P1476

Q28266001-39E8C81B-3B38-459D-9F0E-CC7AB286068E

P2093

Q28266001-1B7AFB97-4379-456D-97C9-871080FDC136

Q28266001-2911CC82-5572-46E2-BC78-895368AE21DE

Q28266001-3EFD7F13-5572-426E-B7F3-F9C1D84C1652

Q28266001-4CD007AC-1B85-434F-AAC0-99972C80AD40

Q28266001-72D49E17-9052-4906-8BAD-7B70D17CDE16

Q28266001-947841CF-5504-4DA7-8B87-FC12D28CE419

Q28266001-A90E1D47-4643-4928-987D-DD11CF43B1E1

Q28266001-BB553F49-460F-41B1-986F-68A80134542B

Q28266001-C4B08ADA-72B2-4479-B306-6AA9F7B03549

P304

Q28266001-CB9A2433-7E23-427C-AF5F-F50C4689682E

P31

Q28266001-DBF52C53-44BA-4BF3-BA89-5AF387B66CE7

P3181

Q28266001-9B22DEB6-1533-4D98-8079-85E9C1027EEA

P356

Q28266001-A1A97421-E86D-491B-99FD-9C1B920D9073

P407

Q28266001-01F65B65-E6F9-42B6-915E-5BFA498DE952

P433

Q28266001-CD8CFCBF-28B8-4F7E-8678-C65CC761F932

P478

Q28266001-95302011-2872-46B7-B863-8FD0FDFC2268

P577

Q28266001-C64CBA91-33D8-4DB8-B75C-6917F0E25811

P698

Q28266001-FFA988F9-F10D-47EB-86BB-A089CCC99F0B

P3181

P356

JCO.2006.06.6944

P1433

Journal of Clinical Oncology

P1476

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

@en

P2093

C Kent Osborne

http://www.w3.org/2001/XMLSchema#string

D Craig Allred

http://www.w3.org/2001/XMLSchema#string

Dennis C Sgroi

http://www.w3.org/2001/XMLSchema#string

Li Ding

http://www.w3.org/2001/XMLSchema#string

Mark G Erlander

http://www.w3.org/2001/XMLSchema#string

Richard A Bender

http://www.w3.org/2001/XMLSchema#string

Susan G Hilsenbeck

http://www.w3.org/2001/XMLSchema#string

Wilson Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Jun Ma

http://www.w3.org/2001/XMLSchema#string

P304

4611-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1097951

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2006.06.6944

http://www.w3.org/2001/XMLSchema#string

P407

P433

28

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17008703

http://www.w3.org/2001/XMLSchema#string